Search Results - "Gandra, Shravanthi"
-
1
Do Muscle Mass, Muscle Density, Strength, and Physical Function Similarly Influence Risk of Hospitalization in Older Adults?
Published in Journal of the American Geriatrics Society (JAGS) (01-08-2009)“…OBJECTIVES: To examine the association between strength, function, lean mass, muscle density, and risk of hospitalization. DESIGN: Prospective cohort study…”
Get full text
Journal Article -
2
Patterns of Teriparatide and Sequential Antiresorptive Agent Treatment Among Elderly Female Medicare Beneficiaries
Published in Journal of bone and mineral research (01-12-2021)“…ABSTRACT The 2020 American Association of Clinical Endocrinologists guidelines for assessing osteoporosis among postmenopausal women stratified postmenopausal…”
Get full text
Journal Article -
3
Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia
Published in Journal of the American Heart Association (06-07-2016)“…Background Apheresis is an important treatment for reducing low‐density lipoprotein cholesterol (LDL‐C) in patients with familial hypercholesterolemia (FH). We…”
Get full text
Journal Article -
4
Cost-Effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain
Published in Clinical therapeutics (01-04-2017)“…Abstract Purpose Our objective was to assess the cost-effectiveness of evolocumab in patients at high risk of cardiovascular (CV) events from the Spanish…”
Get full text
Journal Article -
5
A systematic review to assess adherence and persistence with statins
Published in Current medical research and opinion (03-04-2017)“…Objective: To identify and assess studies published over a 10 year period up to February 2016 which measure adherence or persistence with statins, to summarize…”
Get full text
Journal Article -
6
Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia
Published in Journal of the American Heart Association (01-10-2017)“…Background The proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors evolocumab and alirocumab substantially reduce low‐density lipoprotein…”
Get full text
Journal Article -
7
Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey
Published in Atherosclerosis (01-02-2016)“…Abstract Background and aims Discontinuation of statin therapy by patients with hypercholesterolemia because of the onset of side-effects (statin-associated…”
Get full text
Journal Article -
8
Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
Published in Clinical cardiology (Mahwah, N.J.) (01-06-2016)“…ABSTRACT Randomized trials have shown marked reductions in low‐density lipoprotein cholesterol (LDL‐C), a risk factor for cardiovascular disease (CVD), when…”
Get full text
Journal Article -
9
Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings
Published in Advances in therapy (01-08-2012)“…Background Tumor necrosis factor (TNF)-blockers are approved for use in several immune-related conditions, but treatment patterns, such as switching between…”
Get full text
Journal Article -
10
Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures
Published in BMC health services research (25-06-2015)“…The high acute costs of cardiovascular disease and acute cardiovascular events are well established, particularly in terms of direct medical costs. The costs…”
Get full text
Journal Article -
11
A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary Event
Published in The American journal of cardiology (15-02-2016)“…The objective was to examine real-world treatment patterns of lipid-lowering therapies and their possible associated intolerance and/or ineffectiveness in…”
Get full text
Journal Article -
12
Patient-level costs of major cardiovascular conditions: a review of the international literature
Published in ClinicoEconomics and outcomes research (01-01-2016)“…Robust cost estimates of cardiovascular (CV) events are required for assessing health care interventions aimed at reducing the economic burden of major adverse…”
Get full text
Journal Article -
13
Clustering of Strength, Physical Function, Muscle, and Adiposity Characteristics and Risk of Disability in Older Adults
Published in Journal of the American Geriatrics Society (JAGS) (01-05-2011)“…OBJECTIVES: To empirically identify groupings of strength, physical performance, adiposity, and lean mass and test how such groupings of these interrelated…”
Get full text
Journal Article -
14
Acute and chronic impact of cardiovascular events on health state utilities
Published in BMC health services research (22-04-2015)“…Cost-utility models are frequently used to compare treatments intended to prevent or delay the onset of cardiovascular events. Most published utilities…”
Get full text
Journal Article -
15
The relationship between Lp(a) and CVD outcomes: a systematic review
Published in Lipids in health and disease (17-05-2016)“…Robust associations between lipoprotein(a) [Lp(a)] and CVD outcomes among general populations have been published in previous studies. However, associations in…”
Get full text
Journal Article -
16
Impact of Erythropoiesis-Stimulating Agents on Energy and Physical Function in Nondialysis CKD Patients With Anemia: A Systematic Review
Published in American journal of kidney diseases (01-03-2010)“…Background Previous analyses report the impact of erythropoiesis-stimulating agents (ESAs) on health-related quality of life across various populations. In…”
Get full text
Journal Article -
17
Health-related quality of life of pediatric patients with moderate to severe plaque psoriasis: comparisons to four common chronic diseases
Published in European journal of pediatrics (01-03-2012)“…Health-related quality of life (HRQOL) is an important indicator of the burden of illness in moderate-to-severe plaque psoriasis. This study evaluated…”
Get full text
Journal Article -
18
Impact of Etanercept on Work and Activity Impairment in Employed Moderate to Severe Rheumatoid Arthritis Patients in the United States
Published in Arthritis care & research (2010) (01-10-2013)“…Objective To quantify the impact of etanercept on work and activity impairment in employed US patients with moderate to severe rheumatoid arthritis (RA)…”
Get full text
Journal Article -
19
Productivity losses associated with cardiovascular disease: a systematic review
Published in Expert review of pharmacoeconomics & outcomes research (01-11-2016)“…People with cardiovascular disease (CVD) often require time off work to recover from illness or surgery; for example, following a myocardial infarction (MI) or…”
Get more information
Journal Article -
20
A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia
Published in Advances in therapy (01-11-2015)“…Introduction Few studies have demonstrated the cost burden of cardiovascular events (CVEs) among patients with hyperlipidemia. The primary objective of this…”
Get full text
Journal Article